Morphic Holding, Inc. (NASDAQ:MORF) Receives $61.71 Consensu

Morphic Holding, Inc. (NASDAQ:MORF – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […]

Related Keywords

, Marc Schegerin , Stifel Nicolaus , Praveenp Tipirneni , Blackrock Inc , Securities Exchange Commission , Morphic Holding Inc , Vanguard Group Inc , Pricet Rowe Associates Inc , Berenberg Bank , Nasdaq , Morphic Company Profile , Morphic Holding , Get Free Report , Marketbeat Ratings , Exchange Commission , Street Corp , Vanguard Group , Get Free , Morphic Daily , Amorphic , Nasdaq Morf , Smorf , Medical , Ratings , Consensus ,